Delivery Order SPE2DB24D2205-SPE2DB25FEJBC
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $4,027.70 by the Defense Logistics Agency on September 8, 2025, for the supply of Ingrezza 80 mg capsules (30-count). This non-set-aside competitive award is scheduled for completion by September 29, 2025, and represents a single transaction under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 2, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $14,704.48. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 23, 2025. The contract is funded through the Medical Supply Chain, a Defense-oriented federal agency responsible for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) with a ceiling value of $24,166.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order against AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,049.61 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ingrezza 60 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 23, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed price contract. The award was issued on September 18, 2025, with an ultimate completion date of October 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 7, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to...
- The Defense Logistics Agency awarded a $14.7K delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) with an ultimate completion date of October 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3,676.12. This firm fixed-price delivery order, issued on June 16, 2025, is scheduled for completion by July 9, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order executed under an existing contract vehicle, reflecting the agency's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) with a ceiling value of $4,027.70 and a firm fixed price structure. This order is set to be completed by July 30, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, leveraging its...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEJBCDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively-bid delivery order by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of Ingrezza 80 mg capsules (30-count units). The contract carries a ceiling value of $12,083.10 and is structured as a firm fixed-price delivery order, with an ultimate completion date of October 17, 2025. The performance location is the vendor's corporate office in Conshohocken, PA. This award includes no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. This delivery order falls under AmerisourceBergen's comprehensive Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.99 million through December 2026. This prime contract vehicle supports the military healthcare supply chain by enabling the delivery of a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The award of Ingrezza, a neurological medication, reflects AmerisourceBergen's established role as a critical federal pharmaceutical vendor serving defense healthcare programs including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 9/25/25 |